The impact of systemic lupus erythematosus on the clinical phenotype of antiphospholipid antibody–positive patients: results from the antiphospholipid syndrome …
Objective Although systemic lupus erythematosus (SLE) is the most common autoimmune
disease associated with antiphospholipid antibodies (aPL), limited data exist regarding the …
disease associated with antiphospholipid antibodies (aPL), limited data exist regarding the …
Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
W Qi, J Zhao, C Huang, N Jiang, J Li, C Wu… - Arthritis Research & …, 2022 - Springer
Background Antiphospholipid syndrome (APS) is an autoimmune disease characterized by
persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum …
persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum …
Characteristics of antiphospholipid antibody positive patients in antiphospholipid syndrome alliance for clinical trials and international networking
OBJECTIVE: To describe baseline characteristics of antiphospholipid antibody (aPL)-
positive patients, overall and by clinical and laboratory subtypes, enrolled in an international …
positive patients, overall and by clinical and laboratory subtypes, enrolled in an international …
Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository
Objective To describe the baseline characteristics of patients with positivity for
antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the …
antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the …
Antiphospholipid antibodies in inflammatory and autoimmune rheumatic and musculoskeletal diseases beyond lupus: a systematic review of the available evidence
Background The diagnosis of antiphospholipid syndrome (APS) requires the presence of
thrombosis and/or recurrent miscarriages along with one or more anti-phospholipid …
thrombosis and/or recurrent miscarriages along with one or more anti-phospholipid …
The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
V Venturelli, AM Abrantes, A Rahman… - Rheumatology, 2024 - academic.oup.com
Abstract aPLs are a major determinant of the increased cardiovascular risk in patients with
SLE. They adversely affect clinical manifestations, damage accrual and prognosis. Apart …
SLE. They adversely affect clinical manifestations, damage accrual and prognosis. Apart …
[HTML][HTML] The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
Antiphospholipid syndrome (APS) is the association of thrombosis and/or pregnancy
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …
Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes
DA Gladd, E Olech - Current rheumatology reports, 2009 - Springer
Antiphospholipid antibodies (aPL) occur in a variety of autoimmune, malignant, and
infectious diseases, with or without the thrombotic or obstetric sequelae that characterize the …
infectious diseases, with or without the thrombotic or obstetric sequelae that characterize the …
“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
T Liu, J Gu, L Wan, Q Hu, J Teng, H Liu… - Arthritis research & …, 2020 - Springer
Background Despite expansion in the 2006 Sydney antiphospholipid syndrome (APS)
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …
classification criteria to include IgG/IgM anti-β2-glycoprotein (aβ2GPI) antibodies in addition …
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
MG Tektonidou, K Laskari… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …
lupus anticoagulant (LAC), have been associated with an increased risk of thrombosis in …